Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance

被引:53
作者
Abraham, Ioana [1 ]
El Sayed, Khalid [2 ]
Chen, Zhe-Sheng [1 ]
Guo, Huiqin [3 ]
机构
[1] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Jamaica, NY 11439 USA
[2] Univ Louisiana, Coll Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71201 USA
[3] Peking Union Med Coll Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China
关键词
marine natural products; multidrug resistance; ABC transporters; SOFT-TISSUE SARCOMAS; P-GLYCOPROTEIN; PHASE-II; NATURAL-PRODUCTS; PROTEIN-KINASE; ERIBULIN MESYLATE; DRUG-RESISTANCE; STEROL ACETATE; AGOSTEROL-A; BRYOSTATIN;
D O I
10.3390/md10102312
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
The resistance of tumor cells to a broad range of anticancer agents continues to be a problem for the success of cancer chemotherapy. Multidrug resistance (MDR) is due in part to three drug transporter proteins: ABCB1/P-glycoprotein (P-gp), ABCC1/multidrug resistance protein 1 (MRP1) and ABCG2/breast cancer resistance protein (BCRP). These transporters are part of the ATP-binding cassette (ABC) superfamily, whose members function as ATP-dependent drug-efflux pumps. Their activity can be blocked by various drugs such as verapamil (calcium channel blocker) and cyclosporin A (immunosuppressive agent), etc. These compounds are called MDR modulators or reversals. This review highlights several marine natural products with reversal effect on multidrug resistance in cancer, including agosterol A, ecteinascidin 743, sipholane triterpenoids, bryostatin 1, and welwitindolinones.
引用
收藏
页码:2312 / 2321
页数:10
相关论文
共 49 条
[1]
Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells [J].
Abraham, Ioana ;
Jain, Sandeep ;
Wu, Chung-Pu ;
Khanfar, Mohammad A. ;
Kuang, Yehong ;
Dai, Chun-Ling ;
Shi, Zhi ;
Chen, Xiang ;
Fu, Liwu ;
Ambudkar, Suresh V. ;
El Sayed, Khalid ;
Chen, Zhe-Sheng .
BIOCHEMICAL PHARMACOLOGY, 2010, 80 (10) :1497-1506
[2]
Progress in the development and acquisition of anticancer agents from marine sources [J].
Amador, ML ;
Jimeno, J ;
Paz-Ares, L ;
Cortes-Funes, H ;
Hidalgo, M .
ANNALS OF ONCOLOGY, 2003, 14 (11) :1607-1615
[3]
Agosterol A, a novel polyhydroxylated sterol acetate reversing multidrug resistance from a marine sponge of Spongia sp. [J].
Aoki, S ;
Yoshioka, Y ;
Miyamoto, Y ;
Higuchi, K ;
Setiawan, A ;
Murakami, N ;
Chen, ZS ;
Sumizawa, T ;
Akiyama, S ;
Kobayashi, M .
TETRAHEDRON LETTERS, 1998, 39 (35) :6303-6306
[4]
Reversing effect of agosterol A, a spongean sterol acetate, on multidrug resistance in human carcinoma cells [J].
Aoki, S ;
Chen, ZS ;
Higasiyama, K ;
Setiawan, A ;
Akiyama, S ;
Kobayashi, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (08) :886-895
[5]
Reversal of multidrug resistance in human carcinoma cell line by agosterols, marine spongean sterols. [J].
Aoki, S ;
Setiawan, A ;
Yoshioka, Y ;
Higuchi, K ;
Fudetani, R ;
Chen, ZS ;
Sumizawa, T ;
Akiyama, S ;
Kobayashi, M .
TETRAHEDRON, 1999, 55 (49) :13965-13972
[6]
Intracellular Activation and Deactivation of Tasidotin, an Analog of Dolastatin 15: Correlation with Cytotoxicity [J].
Bai, Ruoli ;
Edler, Michael C. ;
Bonate, Peter L. ;
Copeland, Terry D. ;
Pettit, George R. ;
Luduena, Richard F. ;
Hamel, Ernest .
MOLECULAR PHARMACOLOGY, 2009, 75 (01) :218-226
[7]
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant [J].
Barr, Paul M. ;
Lazarus, Hillard M. ;
Cooper, Brenda W. ;
Schluchter, Mark D. ;
Panneerselvam, Ashok ;
Jacobberger, James W. ;
Hsu, Jack W. ;
Janakiraman, Nalini ;
Simic, Aleksandra ;
Dowlati, Afshin ;
Remick, Scot C. .
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (08) :484-487
[8]
Anticancer Drugs from Marine Flora: An Overview [J].
Boopathy, N. Sithranga ;
Kathiresan, K. .
JOURNAL OF ONCOLOGY, 2010, 2010
[9]
Mammalian ABC transporters in health and disease [J].
Borst, P ;
Elferink, RO .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :537-592
[10]
Trabectedin- A review of its use in the management of soft tissue sarcoma and ovarian cancer [J].
Carter, Natalie J. ;
Keam, Susan J. .
DRUGS, 2007, 67 (15) :2257-2276